Leelamine hydrochloride

CAS No. 16496-99-4

Leelamine hydrochloride( Dehydroabietylamine )

Catalog No. M12521 CAS No. 16496-99-4

Leelamine hydrochloride (Dehydroabietylamine) is a novel inhibitor of androgen receptor (AR).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Leelamine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Leelamine hydrochloride (Dehydroabietylamine) is a novel inhibitor of androgen receptor (AR).
  • Description
    Leelamine hydrochloride (Dehydroabietylamine) is a novel inhibitor of androgen receptor (AR), inhibits castration-resistant prostate cancer cells; causes apoptosis and suppresses 22Rv1 xenograft growth in vivo; Leelamine mediates cancer cell death through inhibition of intracellular cholesterol transport.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Dehydroabietylamine
  • Pathway
    Endocrinology/Hormones
  • Target
    Androgen Receptor (AR)
  • Recptor
    Androgen Receptor (AR)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    16496-99-4
  • Formula Weight
    321.933
  • Molecular Formula
    C20H32ClN
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (77.66 mM)
  • SMILES
    CC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)CN)C.Cl
  • Chemical Name
    1R,2,3,4,4aS,9,10,10aR-octahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenemethanamine, monohydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Singh KB, et al. Mol Cancer Ther. 2018 Jul 20. pii: molcanther.0117.2018. 2. Gowda R, et al. Oncotarget. 2017 Apr 25;8(17):28260-28277. 3. Sehrawat A, et al. Mol Carcinog. 2017 Feb;56(2):337-348. 4. Kuzu OF, et al. Mol Cancer Ther. 2014 Jul;13(7):1690-703.
molnova catalog
related products
  • AR antagonist 1

    AR antagonist 1 is a potent antagonist of the androgen receptor. It binds to E3 ligase ligands with weak binding affinities to VHL protein in the synthesis of PROTAC ARD-266.

  • Enobosarm

    Enobosarm (GTx-024, MK-2866, Ostarine) is a selective androgen receptor modulator (SARM) for the treatment of conditions such as muscle wasting and osteoporosis.

  • BMS-641988 B

    BMS-641988 is a novel nonsteroidal androgen receptor antagonist for the treatment of prostate cancer.